Highlights & Features
What is happening at Canada Annual Meeting
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.
- Foster an understanding of Health Canada's regulatory frameworks and initiatives
- Encourage collaboration between industry, academia, and regulatory bodies to enhance clinical trial processes
- Highlight the importance of patient engagement and inclusion in research and development
- Showcase advancements in AI and technology that support regulatory and clinical operations
- Provide guidance on best practices and emerging trends in drug safety and surveillance
- Offer educational sessions and workshops to improve skills and knowledge in regulatory affairs and clinical research
- Discuss strategies for effective data sharing and transparency in regulatory submissions
- Highlight Canada's unique advantages in conducting clinical trials and fostering innovation
- Hear directly from Health Canada representatives about the latest regulatory initiatives and updates
- Engage with global experts on collaborative approaches to clinical trials, regulatory affairs, safety, and pharmacovigilance
- Connect with industry leaders, regulatory professionals, and fellow attendees during networking sessions
- Explore how artificial intelligence is transforming regulatory practices and clinical development
- Learn how to implement strategies for greater equity and inclusion in clinical trials
- Gain practical insights into pharmacovigilance, electronic labeling, and decentralized trials
- Discover new pathways and strategies for drug development in the rare disease sector
- Prepare for upcoming changes in clinical trial guidelines and regulatory frameworks
Three Educational Tracks: Regulatory, Clinical, Safety and Pharmacovigilance
Track A: Regulatory
The regulatory track provides opportunities for information sharing, use cases, and best practices relating to Canada’s regulatory landscape as it applies to regulatory requirements, new developments, and innovation for life sciences R&D.
Track B: Clinical
Today, modern pharmaceutical, medical device, and diagnostic products are advancing at an unprecedented speed. Sessions in this track will focus on clinical research development and operations for industry. Those interested in this track will gain an understanding of Health Canada’s approach to the modernization of clinical trial regulations and gain further perspectives from patients and those in the life sciences R&D industry.
Track C: Safety and Pharmacovigilance
Our safety and pharmacovigilance track will provide a comprehensive overview of Canada’s regulatory environment in the field of clinical safety and pharmacovigilance for pharmaceutical products and medical devices.
Short Course: Best Practices for Clinical Trial Applications in Canada
November 5, 2024 – 8:30AM ET – 12:30PM ET | Virtual
*Short Courses require an additional registration fee. You do not need to be registered for the forum to attend*
This short course offers a comprehensive exploration of the different aspects of Clinical Trial Applications (CTAs) in Canada including clinical, quality, and publishing and provides a unique opportunity to hear the perspective of both Health Canada and the industry.
Through a combination of Health Canada and Industry speakers, the course will inform professionals in the pharmaceutical, and biotechnology industries, as well as clinical researchers and regulatory affairs specialists, on the requirements and best practices for CTA in Canada.
By the end of the course, the participants will have learned how to address challenges, avoid pitfalls and adopt strategies to ensure the preparation and submission of a high-quality CTA.
Media Partner: N2
The Network of Networks (N2) is a not-for-profit incorporated organization and an alliance of Canadian research networks and organizations working to enhance national clinical research capability and capacity.
Bringing together trialists and clinical research professionals from across the country, N2 provides a common platform for sharing best practices, resources and research-related content to ensure efficient and high-quality research, integrity of clinical practices and accountability.
The organization is truly representative of clinical research in Canada and acts as a national voice and advocate on behalf of a broad range of partners that have an impact on the efficiency and quality of clinical trials conducted in Canada.
Have an account?